Table 4.
No. and type of intramuscularly delivered vaccines as first doses and no. of angioedema attacks following the vaccination (≤72 h).
Total | BNT162b2 | mRNA-1273 | ChAdOx1-S | Ad26.COV2.S | |
---|---|---|---|---|---|
No. of vaccination doses (%) | 202 (100%) | 174 (86.1%) | 16 (7.9%) | 11 (5.5%) | 1 (0.5%) |
No. of angioedema attacks (≤72 h) (%) | 15 (100%) | 12 (80%) | 1 (6.7%) | 1 (6.7%) | 1 (6.7%) |